Jacobs Levy Equity Management’s Patterson Companies, Inc. PDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-75,866
Closed -$1.66M – 1047
2019
Q1
$1.66M Buy
+75,866
New +$1.68M 0.02% 558
2016
Q3
– Sell
-12,500
Closed -$599K – 1149
2016
Q2
$599K Buy
12,500
+980
+9% +$45.2K 0.01% 708
2016
Q1
$536K Sell
11,520
-37,320
-76% -$1.62M 0.01% 710
2015
Q4
$2.21M Sell
48,840
-54,360
-53% -$2.5M 0.04% 325
2015
Q3
$4.46M Buy
103,200
+91,980
+820% +$4.39M 0.09% 230
2015
Q2
$546K Buy
11,220
+2,090
+23% +$99.6K 0.01% 556
2015
Q1
$445K Buy
+9,130
New +$455K 0.01% 592
2014
Q3
– Sell
-5,400
Closed -$213K – 925
2014
Q2
$213K Sell
5,400
-23,858
-82% -$965K ﹤0.01% 758
2014
Q1
$1.22M Sell
29,258
-432,999
-94% -$17.7M 0.02% 493
2013
Q4
$19M Sell
462,257
-194,630
-30% -$8.07M 0.29% 105
2013
Q3
$26.4M Buy
656,887
+490,800
+296% +$19.9M 0.45% 60
2013
Q2
$6.25M Buy
+166,087
New +$6.33M 0.11% 242

Other funds holding PDCO

Jacobs Levy Equity Management's PDCO Position: Q2 2019 in Review

Jacobs Levy Equity Management sold out of Patterson Companies, Inc. (PDCO) in Q2 2019, closing a stake of 75,866 shares — an estimated $1.66M sold.

Jacobs Levy Equity Management first reported a position in PDCO in Q2 2013 and held it in 12 quarters. The position peaked at $26.4M in Q3 2013. 298 funds tracked by Wall St. Rank hold PDCO as of Q2 2019.

  • Jacobs Levy Equity Management reported no remaining Patterson Companies, Inc. position as of Q2 2019 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 75,866 Patterson Companies, Inc. shares in Q2 2019, an estimated $1.66M.
  • Jacobs Levy Equity Management first reported a position in Patterson Companies, Inc. in Q2 2013 and held it in 12 quarters.
  • Jacobs Levy Equity Management's Patterson Companies, Inc. position peaked at $26.4M in Q3 2013.
  • 298 funds tracked by Wall St. Rank held Patterson Companies, Inc. as of Q2 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.